APO Research
Talk to an analyst

APO RESEARCH · REPORT

Toxicological Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Toxicological Testing Market Outlook and Growth Opportunities 2026

1 January 2026201 pages

Choose your research edition.

Industry ResearchToxicological Testing Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Toxicological Testing Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Toxicological Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Toxicological Testing Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Toxicological Testing Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Toxicological Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Toxicological Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Toxicological Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Toxicological Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Toxicological Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Toxicological Testing market include Fraunhofer ITEM, Microbac Laboratories, Jordi Labs, Eurofins Scientific, Redwood Toxicology Laboratory, Abbott Toxicology, Charles River, MedTox and Drugscan, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Toxicological Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Toxicological Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Toxicological Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Toxicological Testing market.

Toxicological Testing Segment by Company

Fraunhofer ITEM

Microbac Laboratories

Jordi Labs

Eurofins Scientific

Redwood Toxicology Laboratory

Abbott Toxicology

Charles River

MedTox

Drugscan

Bio Rad Laboratories Inc

Intertek

BICO Group AB

AquaTox Testing & Consulting

BioIVT LLC

Charles River Laboratories

CompuDrug Ltd.

Evotec SE

Ingenza Ltd.

Toxicological Testing Segment by Type

Acute Toxicity Test

Subacute Toxicity Testing

Chronic Toxicity Test

Allergy Testing

Mutagenicity Test

Long Term Accumulation Test

Toxicological Testing Segment by Application

Hospital

Clinic

Research Institutions

Toxicological Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Toxicological Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Toxicological Testing key companies, revenue, market share, and recent developments.

3. To split the Toxicological Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Toxicological Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Toxicological Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Toxicological Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Toxicological Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Toxicological Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Toxicological Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Toxicological Testing industry.

Chapter 3: Detailed analysis of Toxicological Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Toxicological Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Toxicological Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Toxicological Testing Industry Trends Table 2. Toxicological Testing Industry Drivers Table 3. Toxicological Testing Industry Opportunities and Challenges Table 4. Toxicological Testing Industry Restraints Table 5. Global Toxicological Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Toxicological Testing Revenue Share by Company (2021-2026) Table 7. Global Toxicological Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Toxicological Testing Key Company Manufacturing Base & Headquarters Table 9. Global Toxicological Testing Company, Product Type & Application Table 10. Global Toxicological Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Toxicological Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Acute Toxicity Test Table 15. Significant Companies of Subacute Toxicity Testing Table 16. Significant Companies of Chronic Toxicity Test Table 17. Significant Companies of Allergy Testing Table 18. Significant Companies of Mutagenicity Test Table 19. Significant Companies of Long Term Accumulation Test Table 20. Global Toxicological Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Toxicological Testing Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Toxicological Testing Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Toxicological Testing Sales Value Share by Type (2021-2026) Table 24. Global Toxicological Testing Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Hospital Table 26. Significant Companies of Clinic Table 27. Significant Companies of Research Institutions Table 28. Global Toxicological Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Toxicological Testing Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Toxicological Testing Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Toxicological Testing Sales Value Share by Application (2021-2026) Table 32. Global Toxicological Testing Sales Value Share by Application (2027-2032) Table 33. Global Toxicological Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Toxicological Testing Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Toxicological Testing Sales Value Share by Region (2021-2026) Table 36. Global Toxicological Testing Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Toxicological Testing Sales Value Share by Region (2027-2032) Table 38. Global Toxicological Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Toxicological Testing Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Toxicological Testing Sales Value Market Share by Country (2021-2026) Table 41. Global Toxicological Testing Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Toxicological Testing Sales Value Market Share by Country (2027-2032) Table 43. Fraunhofer ITEM Company Information Table 44. Fraunhofer ITEM Business Overview Table 45. Fraunhofer ITEM Toxicological Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Fraunhofer ITEM Toxicological Testing Product Portfolio Table 47. Fraunhofer ITEM Recent Development Table 48. Microbac Laboratories Company Information Table 49. Microbac Laboratories Business Overview Table 50. Microbac Laboratories Toxicological Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Microbac Laboratories Toxicological Testing Product Portfolio Table 52. Microbac Laboratories Recent Development Table 53. Jordi Labs Company Information Table 54. Jordi Labs Business Overview Table 55. Jordi Labs Toxicological Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Jordi Labs Toxicological Testing Product Portfolio Table 57. Jordi Labs Recent Development Table 58. Eurofins Scientific Company Information Table 59. Eurofins Scientific Business Overview Table 60. Eurofins Scientific Toxicological Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Eurofins Scientific Toxicological Testing Product Portfolio Table 62. Eurofins Scientific Recent Development Table 63. Redwood Toxicology Laboratory Company Information Table 64. Redwood Toxicology Laboratory Business Overview Table 65. Redwood Toxicology Laboratory Toxicological Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Redwood Toxicology Laboratory Toxicological Testing Product Portfolio Table 67. Redwood Toxicology Laboratory Recent Development Table 68. Abbott Toxicology Company Information Table 69. Abbott Toxicology Business Overview Table 70. Abbott Toxicology Toxicological Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Abbott Toxicology Toxicological Testing Product Portfolio Table 72. Abbott Toxicology Recent Development Table 73. Charles River Company Information Table 74. Charles River Business Overview Table 75. Charles River Toxicological Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Charles River Toxicological Testing Product Portfolio Table 77. Charles River Recent Development Table 78. MedTox Company Information Table 79. MedTox Business Overview Table 80. MedTox Toxicological Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. MedTox Toxicological Testing Product Portfolio Table 82. MedTox Recent Development Table 83. Drugscan Company Information Table 84. Drugscan Business Overview Table 85. Drugscan Toxicological Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Drugscan Toxicological Testing Product Portfolio Table 87. Drugscan Recent Development Table 88. Bio Rad Laboratories Inc Company Information Table 89. Bio Rad Laboratories Inc Business Overview Table 90. Bio Rad Laboratories Inc Toxicological Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Bio Rad Laboratories Inc Toxicological Testing Product Portfolio Table 92. Bio Rad Laboratories Inc Recent Development Table 93. Intertek Company Information Table 94. Intertek Business Overview Table 95. Intertek Toxicological Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Intertek Toxicological Testing Product Portfolio Table 97. Intertek Recent Development Table 98. BICO Group AB Company Information Table 99. BICO Group AB Business Overview Table 100. BICO Group AB Toxicological Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. BICO Group AB Toxicological Testing Product Portfolio Table 102. BICO Group AB Recent Development Table 103. AquaTox Testing & Consulting Company Information Table 104. AquaTox Testing & Consulting Business Overview Table 105. AquaTox Testing & Consulting Toxicological Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. AquaTox Testing & Consulting Toxicological Testing Product Portfolio Table 107. AquaTox Testing & Consulting Recent Development Table 108. BioIVT LLC Company Information Table 109. BioIVT LLC Business Overview Table 110. BioIVT LLC Toxicological Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. BioIVT LLC Toxicological Testing Product Portfolio Table 112. BioIVT LLC Recent Development Table 113. Charles River Laboratories Company Information Table 114. Charles River Laboratories Business Overview Table 115. Charles River Laboratories Toxicological Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Charles River Laboratories Toxicological Testing Product Portfolio Table 117. Charles River Laboratories Recent Development Table 118. CompuDrug Ltd. Company Information Table 119. CompuDrug Ltd. Business Overview Table 120. CompuDrug Ltd. Toxicological Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. CompuDrug Ltd. Toxicological Testing Product Portfolio Table 122. CompuDrug Ltd. Recent Development Table 123. Evotec SE Company Information Table 124. Evotec SE Business Overview Table 125. Evotec SE Toxicological Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Evotec SE Toxicological Testing Product Portfolio Table 127. Evotec SE Recent Development Table 128. Ingenza Ltd. Company Information Table 129. Ingenza Ltd. Business Overview Table 130. Ingenza Ltd. Toxicological Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Ingenza Ltd. Toxicological Testing Product Portfolio Table 132. Ingenza Ltd. Recent Development Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Toxicological Testing Product Image Figure 2. Global Toxicological Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Toxicological Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Toxicological Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Acute Toxicity Test Image Figure 8. Subacute Toxicity Testing Image Figure 9. Chronic Toxicity Test Image Figure 10. Allergy Testing Image Figure 11. Mutagenicity Test Image Figure 12. Long Term Accumulation Test Image Figure 13. Global Toxicological Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Toxicological Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Toxicological Testing Sales Value Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Research Institutions Image Figure 19. Global Toxicological Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Toxicological Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Toxicological Testing Sales Value Share by Application (2021-2032) Figure 22. Global Toxicological Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Toxicological Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Toxicological Testing Sales Value (2021-2032) & (US$ Million) Figure 25. North America Toxicological Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Toxicological Testing Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Toxicological Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Toxicological Testing Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Toxicological Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Toxicological Testing Sales Value (2021-2032) & (US$ Million) Figure 31. South America Toxicological Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Toxicological Testing Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Toxicological Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Toxicological Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Toxicological Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Toxicological Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Acute Toxicity Test
  • Subacute Toxicity Testing
  • Chronic Toxicity Test
  • Allergy Testing
  • Mutagenicity Test
  • Long Term Accumulation Test
Applications
  • Hospital
  • Clinic
  • Research Institutions
Companies covered
  • Fraunhofer ITEM
  • Microbac Laboratories
  • Jordi Labs
  • Eurofins Scientific
  • Redwood Toxicology Laboratory
  • Abbott Toxicology
  • Charles River
  • MedTox
  • Drugscan
  • Bio Rad Laboratories Inc
  • Intertek
  • BICO Group AB
  • AquaTox Testing & Consulting
  • BioIVT LLC
  • Charles River Laboratories
  • CompuDrug Ltd.
  • Evotec SE
  • Ingenza Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Toxicological Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Toxicological Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Toxicological Testing Market Dynamics
  1. 2.1 Toxicological Testing Industry Trends
  2. 2.2 Toxicological Testing Industry Drivers
  3. 2.3 Toxicological Testing Industry Opportunities and Challenges
  4. 2.4 Toxicological Testing Industry Restraints
3 Toxicological Testing Market by Company
  1. 3.1 Global Toxicological Testing Company Revenue Ranking in 2025
  2. 3.2 Global Toxicological Testing Revenue by Company (2021-2026)
  3. 3.3 Global Toxicological Testing Company Ranking (2024-2026)
  4. 3.4 Global Toxicological Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Toxicological Testing Company Product Type and Application
  6. 3.6 Global Toxicological Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Toxicological Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Toxicological Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Toxicological Testing Market by Type
  1. 4.1 Toxicological Testing Type Introduction
  2. 4.1.1 Acute Toxicity Test
  3. 4.1.2 Subacute Toxicity Testing
  4. 4.1.3 Chronic Toxicity Test
  5. 4.1.4 Allergy Testing
  6. 4.1.5 Mutagenicity Test
  7. 4.1.6 Long Term Accumulation Test
  8. 4.2 Global Toxicological Testing Sales Value by Type
  9. 4.2.1 Global Toxicological Testing Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Toxicological Testing Sales Value by Type (2021-2032)
  11. 4.2.3 Global Toxicological Testing Sales Value Share by Type (2021-2032)
5 Toxicological Testing Market by Application
  1. 5.1 Toxicological Testing Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Research Institutions
  5. 5.2 Global Toxicological Testing Sales Value by Application
  6. 5.2.1 Global Toxicological Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Toxicological Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Toxicological Testing Sales Value Share by Application (2021-2032)
6 Toxicological Testing Regional Value Analysis
  1. 6.1 Global Toxicological Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Toxicological Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Toxicological Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Toxicological Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Toxicological Testing Sales Value (2021-2032)
  7. 6.3.2 North America Toxicological Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Toxicological Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Toxicological Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Toxicological Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Toxicological Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Toxicological Testing Sales Value (2021-2032)
  16. 6.6.2 South America Toxicological Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Toxicological Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Toxicological Testing Sales Value Share by Country, 2025 VS 2032
7 Toxicological Testing Country-level Value Analysis
  1. 7.1 Global Toxicological Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Toxicological Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Toxicological Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Toxicological Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Toxicological Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Toxicological Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Toxicological Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Toxicological Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Toxicological Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Toxicological Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Toxicological Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Toxicological Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Toxicological Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Toxicological Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Toxicological Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Toxicological Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Toxicological Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Toxicological Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Toxicological Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Toxicological Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Toxicological Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Toxicological Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Toxicological Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Toxicological Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Toxicological Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Toxicological Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Toxicological Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Toxicological Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Toxicological Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Toxicological Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Toxicological Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Toxicological Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Toxicological Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Toxicological Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Toxicological Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Fraunhofer ITEM
  2. 8.1.1 Fraunhofer ITEM Company Information
  3. 8.1.2 Fraunhofer ITEM Business Overview
  4. 8.1.3 Fraunhofer ITEM Toxicological Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Fraunhofer ITEM Toxicological Testing Product Portfolio
  6. 8.1.5 Fraunhofer ITEM Recent Developments
  7. 8.2 Microbac Laboratories
  8. 8.2.1 Microbac Laboratories Company Information
  9. 8.2.2 Microbac Laboratories Business Overview
  10. 8.2.3 Microbac Laboratories Toxicological Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Microbac Laboratories Toxicological Testing Product Portfolio
  12. 8.2.5 Microbac Laboratories Recent Developments
  13. 8.3 Jordi Labs
  14. 8.3.1 Jordi Labs Company Information
  15. 8.3.2 Jordi Labs Business Overview
  16. 8.3.3 Jordi Labs Toxicological Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jordi Labs Toxicological Testing Product Portfolio
  18. 8.3.5 Jordi Labs Recent Developments
  19. 8.4 Eurofins Scientific
  20. 8.4.1 Eurofins Scientific Company Information
  21. 8.4.2 Eurofins Scientific Business Overview
  22. 8.4.3 Eurofins Scientific Toxicological Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eurofins Scientific Toxicological Testing Product Portfolio
  24. 8.4.5 Eurofins Scientific Recent Developments
  25. 8.5 Redwood Toxicology Laboratory
  26. 8.5.1 Redwood Toxicology Laboratory Company Information
  27. 8.5.2 Redwood Toxicology Laboratory Business Overview
  28. 8.5.3 Redwood Toxicology Laboratory Toxicological Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Redwood Toxicology Laboratory Toxicological Testing Product Portfolio
  30. 8.5.5 Redwood Toxicology Laboratory Recent Developments
  31. 8.6 Abbott Toxicology
  32. 8.6.1 Abbott Toxicology Company Information
  33. 8.6.2 Abbott Toxicology Business Overview
  34. 8.6.3 Abbott Toxicology Toxicological Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Abbott Toxicology Toxicological Testing Product Portfolio
  36. 8.6.5 Abbott Toxicology Recent Developments
  37. 8.7 Charles River
  38. 8.7.1 Charles River Company Information
  39. 8.7.2 Charles River Business Overview
  40. 8.7.3 Charles River Toxicological Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Charles River Toxicological Testing Product Portfolio
  42. 8.7.5 Charles River Recent Developments
  43. 8.8 MedTox
  44. 8.8.1 MedTox Company Information
  45. 8.8.2 MedTox Business Overview
  46. 8.8.3 MedTox Toxicological Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MedTox Toxicological Testing Product Portfolio
  48. 8.8.5 MedTox Recent Developments
  49. 8.9 Drugscan
  50. 8.9.1 Drugscan Company Information
  51. 8.9.2 Drugscan Business Overview
  52. 8.9.3 Drugscan Toxicological Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Drugscan Toxicological Testing Product Portfolio
  54. 8.9.5 Drugscan Recent Developments
  55. 8.10 Bio Rad Laboratories Inc
  56. 8.10.1 Bio Rad Laboratories Inc Company Information
  57. 8.10.2 Bio Rad Laboratories Inc Business Overview
  58. 8.10.3 Bio Rad Laboratories Inc Toxicological Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bio Rad Laboratories Inc Toxicological Testing Product Portfolio
  60. 8.10.5 Bio Rad Laboratories Inc Recent Developments
  61. 8.11 Intertek
  62. 8.11.1 Intertek Company Information
  63. 8.11.2 Intertek Business Overview
  64. 8.11.3 Intertek Toxicological Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Intertek Toxicological Testing Product Portfolio
  66. 8.11.5 Intertek Recent Developments
  67. 8.12 BICO Group AB
  68. 8.12.1 BICO Group AB Company Information
  69. 8.12.2 BICO Group AB Business Overview
  70. 8.12.3 BICO Group AB Toxicological Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BICO Group AB Toxicological Testing Product Portfolio
  72. 8.12.5 BICO Group AB Recent Developments
  73. 8.13 AquaTox Testing & Consulting
  74. 8.13.1 AquaTox Testing & Consulting Company Information
  75. 8.13.2 AquaTox Testing & Consulting Business Overview
  76. 8.13.3 AquaTox Testing & Consulting Toxicological Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AquaTox Testing & Consulting Toxicological Testing Product Portfolio
  78. 8.13.5 AquaTox Testing & Consulting Recent Developments
  79. 8.14 BioIVT LLC
  80. 8.14.1 BioIVT LLC Company Information
  81. 8.14.2 BioIVT LLC Business Overview
  82. 8.14.3 BioIVT LLC Toxicological Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BioIVT LLC Toxicological Testing Product Portfolio
  84. 8.14.5 BioIVT LLC Recent Developments
  85. 8.15 Charles River Laboratories
  86. 8.15.1 Charles River Laboratories Company Information
  87. 8.15.2 Charles River Laboratories Business Overview
  88. 8.15.3 Charles River Laboratories Toxicological Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Charles River Laboratories Toxicological Testing Product Portfolio
  90. 8.15.5 Charles River Laboratories Recent Developments
  91. 8.16 CompuDrug Ltd.
  92. 8.16.1 CompuDrug Ltd. Company Information
  93. 8.16.2 CompuDrug Ltd. Business Overview
  94. 8.16.3 CompuDrug Ltd. Toxicological Testing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CompuDrug Ltd. Toxicological Testing Product Portfolio
  96. 8.16.5 CompuDrug Ltd. Recent Developments
  97. 8.17 Evotec SE
  98. 8.17.1 Evotec SE Company Information
  99. 8.17.2 Evotec SE Business Overview
  100. 8.17.3 Evotec SE Toxicological Testing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Evotec SE Toxicological Testing Product Portfolio
  102. 8.17.5 Evotec SE Recent Developments
  103. 8.18 Ingenza Ltd.
  104. 8.18.1 Ingenza Ltd. Company Information
  105. 8.18.2 Ingenza Ltd. Business Overview
  106. 8.18.3 Ingenza Ltd. Toxicological Testing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Ingenza Ltd. Toxicological Testing Product Portfolio
  108. 8.18.5 Ingenza Ltd. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst